Anti-Acne Support
On Wednesday, the Food and Drug Administration issued a warning, calling compounded GLP-1 medications "risky for patients." "FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs, including semaglutide and tirzepatide, as an option for weight loss," the FDA said
The cardiovascular evidence gap matters in two directions: it is a hard advantage for semaglutide on documented benefit, and an unknown for retatrutide that the glucagon-receptor arm makes worth watching specifically (glucagon-agonist effects on heart rate and metabolic rate are documented but the long-term MACE signal is open)
While the brand remains focused on high-protein offerings, the Oikos portfolio is intentionally diversified, Danone told us with each product delivering distinct, targeted and complimentary benefits that meet a variety of consumer health goals
10.1038/srep39884 [DOI] [PMC free article] [PubMed] [Google Scholar] 92.Wang, M., Lin, X., Yang, X
Moyers JS
